ONO-6950 Phase I Study

ONO-6950 Phase I Study (Single-dose, oral administration)

Status

Unknown

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221411

Enrollment

Registered

2011-03-25

Start date

2011-03-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

investigational material(s) Generic name etc : ONO-6950 INN of investigational material : Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational mater

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Japanese healthy adult 2. BMI of 18.5=< <25kg/m2

Exclusion criteria

Exclusion criteria: 1. Subject who has history or presence of clinically significant respiratory/pulmonary, cardiovascular, neurologic, psychiatric, digestive, hepatic, renal, hematopoietic, endocrine/metabolic diseases or disorders, and who is disqualified from the study at the discretion of primary investigator or sub-investigator.

Design outcomes

Primary

Measure	Time frame
safety and pharmacokinetics	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026